spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MOZOBIL 

 HSMN NewsFeed - 20 Jul 2022
Nuvalent Announces Leadership Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jan 2014
Tekmira Announces Strategic Reorganization to Strengthen Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2009
Inimex Announces Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jan 2009
ARIAD Expands Management Team with Executive Appointments in Regulatory Affairs, Manufacturing and Information Technology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2008
FDA Approves Genzyme's Mozobil
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Jul 2007
Genzyme Announces Phase 3 Trial of Mozobil in non-Hodgkin's Lymphoma Meets Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Nov 2006
Genzyme Completes Tender Offer for Outstanding Shares of AnorMED
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2006
Genzyme and AnorMED Reach Agreement on Acquisition
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2006
AnorMED has determined Genzyme's offer is a 'superior proposal'
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Oct 2006
Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Sep 2006
Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2006
Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Sep 2006
AnorMED amends license agreement for cancer drug
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Jul 2006
AnorMED completes enrollment in Phase III trial for MOZOBIL in stem cell transplant in multiple myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 May 2006
AnorMED President and CEO Michael Abrams steps down
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 3 additional stories matching:
MOZOBIL
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.